Practice Patterns and In-Hospital Outcomes Associated With Bivalirudin Use Among Patients With Non-ST-SegmentElevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the United States

摘要

Background-Practice patterns in anticoagulant strategies used during percutaneous coronary intervention (PCI) in the United States for patients with non-ST-segment-elevation myocardial infarction and the comparative outcomes between bivalirudin and unfractionated heparin (UFH) have not been well described.